rs121908801
From SNPedia
| Cystic Fibrosis related |
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (-;A) | 3 | Likely miscall by 23andMe; but if not, carrier of a cystic fibrosis allele |
| (A;A) | 0 | common in clinvar |
| Make rs121908801(-;-) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 7 |
| Position | 117530938 |
| Gene | CFTR |
| is a | snp |
| is | mentioned by |
| dbSNP | rs121908801 |
| dbSNP (classic) | rs121908801 |
| ClinGen | rs121908801 |
| ebi | rs121908801 |
| HLI | rs121908801 |
| Exac | rs121908801 |
| Gnomad | rs121908801 |
| Varsome | rs121908801 |
| LitVar | rs121908801 |
| Map | rs121908801 |
| PheGenI | rs121908801 |
| Biobank | rs121908801 |
| 1000 genomes | rs121908801 |
| hgdp | rs121908801 |
| ensembl | rs121908801 |
| geneview | rs121908801 |
| scholar | rs121908801 |
| rs121908801 | |
| pharmgkb | rs121908801 |
| gwascentral | rs121908801 |
| openSNP | rs121908801 |
| 23andMe | rs121908801 |
| SNPshot | rs121908801 |
| SNPdbe | rs121908801 |
| MSV3d | rs121908801 |
| GWAS Ctlg | rs121908801 |
| Max Magnitude | 3 |
Cystic fibrosis; c.313delA, Ile105Serfs
Note: the 23andMe SNP representing this variant, i5010812, appears to often be miscalled as heterozygous.
| ClinVar | |
|---|---|
| Risk | rs121908801(-;-) |
| Alt | rs121908801(-;-) |
| Reference | Rs121908801(A;A) |
| Significance | Pathogenic |
| Disease | Cystic fibrosis |
| Variation | info |
| Gene | CFTR |
| CLNDBN | Cystic fibrosis |
| Reversed | 0 |
| HGVS | NC_000007.13:g.117170992delA |
| CLNSRC | CFTR2 Cystic Fibrosis Mutation Database |
| CLNACC | RCV000046792.3, |
[PMID 11388756] Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel.
[PMID 12007216] Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.
[PMID 15371903] CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations.
